Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
about
From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionTowards an understanding of the painful total knee: what is the role of patient biology?Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in miceInfluence of interleukin-1 beta gene polymorphisms on the risk of myocardial infarction and ischemic stroke at young age in vivo and in vitro.Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum".Disordered haematopoiesis and athero-thrombosis.Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction.Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.Differential Regulation of Cardiac Function and Intracardiac Cytokines by Rapamycin in Healthy and Diabetic Rats.Monocytes and macrophages in cardiac injury and repair.Inflammation - Cause or Consequence of Heart Failure or Both?Challenges and opportunities in treating inflammation associated with pulmonary hypertension.The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.E-Selectin Inhibition Mitigates Splenic HSC Activation and Myelopoiesis in Hypercholesterolemic Mice With Myocardial Infarction.Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure.The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology.Antiarrhythmic effects of interleukin 1 inhibition after myocardial infarction.Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes.Non-Invasive Immuno-Metabolic Cardiac Inflammation Imaging Using Hyperpolarized Magnetic Resonance.Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury.Resident and Monocyte-Derived Macrophages in Cardiovascular Disease.Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins.Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.Mapping macrophage polarization over the myocardial infarction time continuum.Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients.Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibitionNew Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell TypesThe Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4)
P2860
Q26770209-578A7EA3-0586-40C8-9A76-8D5A950F7F66Q28066351-2AA32FB1-706A-4DDF-B692-800AFAF1F5EDQ34549707-66EF19A5-6828-49DE-9D00-5ADA986BA11DQ36464263-69D34E2B-F3E2-4AF2-910F-C42EB5C2520EQ36654171-ED117E43-3A04-4A2D-B721-A25F29884F92Q36773876-9343F855-0142-4545-9D15-2A85086C7FE0Q37338935-50445881-CA39-4F67-BB47-20C0116B62EAQ37445494-0ACEC341-8520-49E1-9456-37FCB70A9FACQ37603197-9748D870-A2B5-481F-A132-D63757C32C99Q37734346-EFC1C368-FCF1-4CA4-AA10-9049900180D7Q37740369-862EF22C-1D29-4F5B-B0F2-783D583D2693Q38664204-5B931924-C3A6-4B0E-85DD-1998BBA216AAQ38812727-F6AFA5E0-89E0-41B4-9C0C-2C549EBD76E5Q38875774-EE63166F-139A-47FF-8060-EB4A769FFED3Q40959059-DD43F690-35D5-4B8B-97AB-7C63926A27BFQ41728608-912A2977-9913-4333-B004-4B4CA8D639F1Q45069046-09E89DC5-F66F-46F3-8556-BBA8CAAE833BQ46173512-63E226E7-5A31-40C3-B956-74F8688ACFC3Q47599422-A77CA3D7-96D7-4CAE-B92A-8BBA9061CECDQ47696973-68AF829C-0BDB-4252-8BE3-D35987D13DACQ50027672-EB6BD135-8409-4207-A0C3-E13D7158CCE6Q50044861-C0DE1E73-6D95-4E24-AD0B-8B69DD6B605BQ50187351-2A98C0F6-84EB-4D10-8186-6292E2471F01Q50560471-05AD9DD5-47C6-433F-946F-655C65EC3BB7Q52730911-BAA9F9F2-1335-4FE8-8BE3-52B44FA98686Q55234249-8BED2FC0-8CDB-46A0-BEE6-97348ED0D713Q55318421-10D36A16-231C-4D6A-907F-B4B41375F054Q55332127-00030EA6-71FE-4A7D-965E-AD52EEDB2910Q57162899-CCFC475C-10F9-4731-87BB-1EF2E46EC55FQ57176906-DD55FEC6-EF3F-4B48-878E-0F72D90290A1Q58592667-A20FE159-2D3B-421E-939E-11BBF6286C02
P2860
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
@ast
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
@en
type
label
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
@ast
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
@en
prefLabel
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
@ast
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
@en
P2093
P2860
P50
P1433
P1476
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
@en
P2093
Benoit Tricot
Hendrik B Sager
Matthew Sebas
Matthias Nahrendorf
Partha Dutta
Peter Libby
Timo Heidt
Yoshiko Iwamoto
P2860
P304
P356
10.1161/CIRCULATIONAHA.115.016160
P407
P577
2015-09-10T00:00:00Z